AI-generated summary
The authors ran a double-blind randomized trial of bright light therapy as an add-on treatment in 101 adults with medically intractable focal epilepsy, comparing a high-intensity light box with a low-intensity one. They found no significant difference in responder rates between the two groups. Some patterns suggested possible benefit in patients with hippocampal sclerosis, but the authors report these were not statistically clear and warrant further study.
- Participants
- 101
- Who or what was studied
- Adults with medically intractable focal epilepsy
- Limits stated in the abstract
- The abstract reports no significant between-group difference, and the hippocampal sclerosis finding was not statistically clear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Primary outcome, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.